Cypress Wealth Services, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1721527
PALM DESERT, CA
Position in BCRX
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$200,000
+$9,600 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#207
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Derivatives in BCRX
reported options exposure · as of Sep 30, 2020CallValue
$0
CallShares
0
PutValue
$51,600
PutShares
15,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cypress Wealth Services, LLC holds $200,000 across 1 Drug Manufacturers - Specialty & Generic name. BCRX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
20,000 | $200,000 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,000 | 20,000 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $190,400 | 20,000 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $156,000 | 20,000 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $151,800 | 20,000 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $179,200 | 20,000 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $150,000 | 20,000 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $150,400 | 20,000 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $152,000 | 20,000 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $123,600 | 20,000 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $101,600 | 20,000 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $119,800 | 20,000 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $141,600 | 20,000 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $140,800 | 20,000 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $166,800 | 20,000 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $229,600 | 20,000 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $252,000 | 20,000 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $211,600 | 20,000 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $325,200 | 20,000 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $277,000 | 20,000 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $287,400 | 20,000 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $316,200 | 20,000 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $203,400 | 20,000 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $149,000 | 20,000 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $51,600 | 15,000 | Put | Sole | 2020-10-23 | |
| 2020-06-30 | $47,600 | 10,000 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $20,000 | 10,000 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||